Search Results

Return to List
Results 1–20 of 92
Title Date
1.

Hospital-Based Triage of Obstetric Patients

Number 667

ABSTRACT Emergency departments typically have structured triage guidelines for health care providers encountering the diverse cases that may present to their units Such guidelines aid in determining which patients must be evaluated promptly and which may wait safely and aid in determining anticipa...

July 2016

PDF Format
2.

Optimizing Postpartum Care

Number 666

ABSTRACT In the weeks after birth postpartum care often is fragmented among maternal and pediatric health care providers and communication between inpatient and outpatient settings is inconsistent To optimize postpartum care anticipatory guidance should begin during pregnancy During antenatal care...

June 2016

PDF Format
3.

Refusal of Medically Recommended Treatment During Pregnancy

Number 664

(Replaces Committee Opinion Number 321, November 2005)

ABSTRACT One of the most challenging scenarios in obstetric care occurs when a pregnant patient refuses recommended medical treatment that aims to support her wellbeing her fetuss wellbeing or both In such circumstances the obstetriciangynecologists ethical obligation to safeguard the pregnant wom...

June 2016

PDF Format
4.

Integrating Immunizations Into Practice

Number 661

ABSTRACT Immunization against vaccinepreventable diseases is an essential component of womens primary and preventive health care Despite the importance of vaccination and clear guidance from public health agencies rates of vaccination lag behind national goals Obstetriciangynecologists can play a ...

April 2016

PDF Format
5.

Family Building Through Gestational Surrogacy

Number 660

(Replaces Committee Opinion No. 397, February 2008)

ABSTRACT Gestational surrogacy is an increasingly common form of family building that can allow individuals or a couple to become parents despite circumstances in which carrying a pregnancy is biologically impossible or medically contraindicated The practice of gestational surrogacy involves a wom...

March 2016

PDF Format
6.

Magnesium Sulfate Use in Obstetrics

Number 652

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format
7.

Physical Activity and Exercise During Pregnancy and the Postpartum Period

Number 650

(Replaces Committee Opinion Number 267, January 2002)

ABSTRACT Physical activity in all stages of life maintains and improves cardiorespiratory fitness reduces the risk of obesity and associated comorbidities and results in greater longevity Physical activity in pregnancy has minimal risks and has been shown to benefit most women although some modifi...

December 2015

PDF Format
8.

Umbilical Cord Blood Banking

Number 648

(Replaces Committee Opinion Number 399, February 2008)

ABSTRACT Once considered a waste product that was discarded with the placenta umbilical cord blood is now known to contain potentially lifesaving hematopoietic stem cells When used in hematopoietic stem cell transplantation umbilical cord blood offers several distinct advantages over bone marrow o...

December 2015

PDF Format
9.

Dual Therapy for Gonococcal Infections

Number 645

ABSTRACT Gonorrhea is the second most commonly reported bacterial sexually transmitted disease in the United States with an estimated 820000 new Neisseria gonorrhoeae infections occurring each year Antimicrobial resistance limits treatment success heightens the risk of complications and may facili...

November 2015

PDF Format
10.

The Apgar Score

Number 644

(Replaces Committee Opinion Number 333, May 2006)

ABSTRACT The Apgar score provides an accepted and convenient method for reporting the status of the newborn infant immediately after birth and the response to resuscitation if needed The Apgar score alone cannot be considered to be evidence of or a consequence of asphyxia does not predict individu...

October 2015

PDF Format
11.

Identification and Referral of Maternal Genetic Conditions in Pregnancy

Number 643

ABSTRACT Advances in the understanding of genetic conditions reproductive technologies and improved medical and surgical care have enabled an increasing number of women with genetic conditions to achieve a normal pregnancy outcome However management of certain genetic conditions during pregnancy i...

October 2015

PDF Format
12.

Cell-free DNA Screening for Fetal Aneuploidy

Number 640

(This Committee Opinion Replaces Committee Opinion Number 545)

ABSTRACT Noninvasive prenatal screening that uses cellfree DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy A number of laboratories have validated different techniques for the use of cellfree DNA as a screening test for fetal aneuploidy ...

September 2015

PDF Format
13.

The Importance of Vital Records and Statistics for the Obstetrician-Gynecologist

Number 639

ABSTRACT Information from vital records is critical to identify and quantify healthrelated issues and to measure progress toward quality improvement and public health goals In particular maternal and infant mortality serve as important indicators of the nations health thereby influencing policy de...

September 2015

PDF Format
14.

First-Trimester Risk Assessment for Early-Onset Preeclampsia

Number 638

ABSTRACT Hypertensive disorders with adverse sequelae including preterm birth maternal morbidity and mortality and longterm risk of maternal cardiovascular disease complicate 510 of pregnancies Early identification of pregnant women at risk of developing earlyonset preeclampsia would theoretically...

September 2015

PDF Format
15.

Marijuana Use During Pregnancy and Lactation

Number 637

ABSTRACT Cannabis sativa marijuana is the illicit drug most commonly used during pregnancy The selfreported prevalence of marijuana use during pregnancy ranges from 2 to 5 in most studies A growing number of states are legalizing marijuana for medicinal or recreational purposes and its use by preg...

July 2015

PDF Format
16.

Management of Women With Phenylketonuria

Number 636

(Replaces Committee Opinion Number 449, December 2009)

ABSTRACT Phenylketonuria PKU is an autosomal recessive disorder of phenylalanine Phe metabolism characterized by deficient activity of the hepatic enzyme phenylalanine hydroxylase Increased blood Phe levels are toxic to a variety of tissues particularly the developing fetal brain The mainstay of t...

June 2015

PDF Format
17.

Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

Number 635

(Replaces Committee Opinion Number 418, September 2008)

ABSTRACT Given the enormous advances in the prevention of perinatal transmission of human immunodeficiency virus HIV it is clear that early identification and treatment of all pregnant women with HIV is the best way to prevent neonatal infection and also improve womens health Furthermore new evide...

June 2015

PDF Format
18.

Screening for Perinatal Depression

Number 630

(Replaces Committee Opinion Number 453, February 2010)

ABSTRACT Perinatal depression which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery is one of the most common medical complications during pregnancy and the postpartum period affecting one in seven women It is important to identify ...

May 2015

PDF Format
19.

Health Care for Unauthorized Immigrants

Number 627

(Replaces Committee Opinion Number 425, January 2009)

ABSTRACT Unauthorized undocumented immigrants are less likely than other residents of the United States to have health insurance The American College of Obstetricians and Gynecologists has long supported a basic health care package for all women living within the United States without regard to th...

March 2015

PDF Format
20.

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Number 623

(Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998